text.skipToContent text.skipToNavigation

HP1 | ((4-{5-[2-chlorethyl)(2-hydroxyethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid)

Internal Heraeus Name: HP1 | ((4-{5-[2-chlorethyl)(2-hydroxyethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid)

Product Details

  • ID
    5012227
  • Product Type
    Standard  
  • Packaging/Sample size
    0,1  g
  • Packaging Type
    Glass vials  

Danger

Pricing

Price excl. VAT, incl. shipping and packaging

Quantity/UoM Base

Order Quantity
Increasing order volume can lead to reduced price per unit of measure.
Request for Quote

Additional Information

Classification of the Substance or Mixture

Acute toxicity Category 3 | H301: Toxic if swallowed.
Germ cell mutagenicity Category 1B | H340: May cause genetic defects.
Carcinogenicity Category 1A | H350: May cause cancer.
Reproductive toxicity Category 1B | H360: May damage fertility or the unborn child.
Specific target organ toxicity - repeated exposure Category 2 | H373: May cause damage to organs through prolonged or repeated exposure.

Description

Chemical formula C16H22ClN3O3
Chemical name (4-{5-[2-chlorethyl)(2-hydroxyethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid)

Identification

Heraeus Ident-No. 5012227
CAS - Number 109882-27-1
Request product modification

Documents

Request a document

Benefits and Applications

Classification of the Substance or Mixture (outside EU)